Teneobio
AcquiredNewark, United States · $30.0M raised
- Headquarters
- Newark, California
- Employees
- 51–200
- Business Model
- B2B
- Website
- teneobio.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AMar 2016
- Rounds
- 1
- Acquired by
- AmgenJul 2022 · $100.0M
About
Clinical-stage biotech developing UniAb human heavy-chain antibodies as a new class of biologics for disease treatment.
Summary
Teneobio is a Biotech company based in Newark, United States. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Mar 2016. Investors include AstraZeneca, Amgen and Lightspeed Venture Partners.
Funding History
Jul 2022
Sign up to see all 3 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/teneobio"><img src="https://indexed.vc/api/badge/company/teneobio" alt="Teneobio on Indexed.vc" width="260" height="76" /></a>